Search for Clinical Trial Results
Intraocular Lymphoma - 25 Studies Found
Status | Study |
Terminated |
Study Name: CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Condition:
Interventions: |
Terminated |
Study Name: PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma Condition:
Interventions: |
Completed |
Study Name: PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas Condition:
|
Completed |
Study Name: MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas Condition:
|
Terminated |
Study Name: MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma Condition:
Interventions: |
Terminated |
Study Name: Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection Condition:
|
Completed |
Study Name: Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma Condition:
Interventions: |
Completed |
Study Name: Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma Condition:
Interventions: |